Patents by Inventor Vito M. Fazio

Vito M. Fazio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti tumoral immunogenic peptides and vaccine thereof
    Patent number: 9150627
    Abstract: The invention relates to novel, Frizzled-like, immunogenic peptides, useful for the stimulation of an immune response against various cancer types, particularly colon rectal carcinoma.
    Type: Grant
    Filed: December 29, 2005
    Date of Patent: October 6, 2015
    Inventors: Vito M. Fazio, Enrico Garaci, Guido Rasi, Monica Rinaldi, Paola Sinibaldi
  • ANTI TUMORAL IMMUNOGENIC PEPTIDES AND VACCINE THEREOF
    Publication number: 20090232837
    Abstract: The invention relates to novel, Frizzled-like, immunogenic peptides, useful for the stimulation of an immune response against various cancer types, particularly colon rectal carcinoma.
    Type: Application
    Filed: December 29, 2005
    Publication date: September 17, 2009
    Inventors: Vito M. Fazio, Enrico Garaci, Guido Rasi, Monica Rinaldi, Paola Sinibaldi
  • DNA vaccines expressing hypervariable VH-CDR3 idiotypic determinants
    Patent number: 7354759
    Abstract: The present invention relates to a method for inducing the immune response of an individual against B-lymphoproliferative disorders. The method is based on DNA vaccination with the short peptide encompassing the CDR3 hypervariable region of immunoglobulin heavy chain (VH-CDR3) alone or in combination with at least another immunomodulating sequence.
    Type: Grant
    Filed: January 15, 2001
    Date of Patent: April 8, 2008
    Assignee: Keryos SpA
    Inventors: Vito M. Fazio, Giuseppe Saglio
  • Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants
    Publication number: 20040109849
    Abstract: The present invention relates to a method for inducing the immune response of an individual against B-lymphoproliferative disorders. The method is based on DNA vaccination with the short peptide encompassing the CDR3 hypervariable region of immunoglobulin heavy chain (VH-CDR3) alone or in combination with at least another immunomodulating sequence.
    Type: Application
    Filed: December 8, 2003
    Publication date: June 10, 2004
    Inventors: Vito M Fazio, Giuseppe Saglio